Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.
Anastasilakis AD, Polyzos SA, Makras P, Gkiomisi A, Sakellariou G, Savvidis M, Papatheodorou A, Kokkoris P, Terpos E. Anastasilakis AD, et al. Among authors: makras p. Expert Opin Ther Targets. 2015 Mar;19(3):299-306. doi: 10.1517/14728222.2014.983078. Epub 2014 Nov 14. Expert Opin Ther Targets. 2015. PMID: 25395071 Clinical Trial.
Cost-effective osteoporosis treatment thresholds in Greece.
Makras P, Athanasakis K, Boubouchairopoulou N, Rizou S, Anastasilakis AD, Kyriopoulos J, Lyritis GP. Makras P, et al. Osteoporos Int. 2015 Jul;26(7):1949-57. doi: 10.1007/s00198-015-3055-8. Epub 2015 Mar 5. Osteoporos Int. 2015. PMID: 25740208
Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.
Anastasilakis AD, Polyzos SA, Gkiomisi A, Saridakis ZG, Digkas D, Bisbinas I, Sakellariou GT, Papatheodorou A, Kokkoris P, Makras P. Anastasilakis AD, et al. Among authors: makras p. Osteoporos Int. 2015 Oct;26(10):2521-7. doi: 10.1007/s00198-015-3174-2. Epub 2015 May 20. Osteoporos Int. 2015. PMID: 25990355 Clinical Trial.
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Hadji P, Papaioannou N, Gielen E, Feudjo Tepie M, Zhang E, Frieling I, Geusens P, Makras P, Resch H, Möller G, Kalouche-Khalil L, Fahrleitner-Pammer A. Hadji P, et al. Among authors: makras p. Osteoporos Int. 2015 Oct;26(10):2479-89. doi: 10.1007/s00198-015-3164-4. Epub 2015 May 28. Osteoporos Int. 2015. PMID: 26018090 Free PMC article.
151 results